Compare CRNX & FE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRNX | FE |
|---|---|---|
| Founded | 2008 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 23.9B |
| IPO Year | 2018 | N/A |
| Metric | CRNX | FE |
|---|---|---|
| Price | $49.27 | $44.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 14 |
| Target Price | ★ $71.00 | $48.33 |
| AVG Volume (30 Days) | 1.1M | ★ 4.6M |
| Earning Date | 11-06-2025 | 10-22-2025 |
| Dividend Yield | N/A | ★ 4.01% |
| EPS Growth | N/A | ★ 48.81 |
| EPS | N/A | ★ 2.31 |
| Revenue | $1,535,000.00 | ★ $14,283,000,000.00 |
| Revenue This Year | $425.31 | $10.15 |
| Revenue Next Year | $943.50 | $3.69 |
| P/E Ratio | ★ N/A | $19.25 |
| Revenue Growth | ★ 47.74 | 7.74 |
| 52 Week Low | $24.10 | $37.58 |
| 52 Week High | $54.78 | $48.20 |
| Indicator | CRNX | FE |
|---|---|---|
| Relative Strength Index (RSI) | 59.09 | 43.59 |
| Support Level | $43.04 | $43.91 |
| Resistance Level | $49.75 | $44.81 |
| Average True Range (ATR) | 2.14 | 0.56 |
| MACD | -0.09 | -0.01 |
| Stochastic Oscillator | 76.20 | 45.03 |
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
FirstEnergy is an investor-owned holding company with 10 regulated distribution utilities across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems.